Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
No substantial benefit from transplantation reported for a high-risk leukemia subtype
Children with hypodiploid acute lymphoblastic leukemia fare better when minimal residual disease is used to guide treatment.
-
More accurate leukemia diagnosis expected as researchers refine leukemia classification
Research led by St. Jude Children's Research Hospital means more than 90 percent of the most common cases of childhood cancer can now be classified by subtype, an advance likely to fuel precision medicine.
-
Research reveals machinery of a deadly childhood brain cancer
Investigators studied the effects of the H3 K27M mutation, and revealed its impact on mutations that are known drivers of DIPGs.
-
Newly identified subset of immune cells may be key to fighting chronic inflammation
Read about the newly identified subset of helper T 17 immune cells that suggest a novel approach for taming chronic inflammation.
-
Researchers report how molecular partners form dynamic scaffolding for protein machinery
Scientific discovery by St. Jude group could lead to new pathway for cancer treatment and understanding of ALS.
-
St. Jude research into leukemia, sickle cell and other blood disorders presented at ASH
The 2018 annual meeting of the American Society of Hematology will include research from St. Jude that stretches from the laboratory to the clinic.
